Warning: Declaration of TCB_Menu_Walker::walk($elements, $max_depth) should be compatible with Walker::walk($elements, $max_depth, ...$args) in /home/neworgan/public_html/wp-content/plugins/thrive-visual-editor/inc/classes/class-tcb-menu-walker.php on line 0
Bioprinters - New Organ Alliance

bioPrinters

[breadcrumb]

improved bioprinters
technology topic

BioPrinting Capabilities Map.

Keeping up on all the real-time advancements in bioprinting technology is in itself a challenge.


The development of an information platform that includes real time comprehensive information about existing bioprinting capabilities and provides information and updates of emerging trends and capabilities in real-time is a necessity. 


Real time update should include but not be limited to:


  • Resolution, precision and accuracy of printer technologies
  • Number of material types and categories (ECM, hydrogel, cell types..etc) that each technology can print
  • Design Software and process flow
  • Medical Imaging and Data storage & handling requirements
  • Post printing characterization, storage, and special requirements for maintaining sterile environment and sterilization before application!
  • Technology gaps and opportunities for 3DBioP technology improvements
  • Funding opportunities for technology maturation and application driven productization
  • Regulatory and Standards relevant to 3DBioP
  • Technology challenges verses application specific engineering challenges

Vertical Maturation of BioPrinter Technology

The most of the 3DBioP technology capabilities are matured and advanced horizontally, and we need to stimulate the vertical maturation and advancement of 3DBioP with the incorporation of complimentary emerging technological capabilities for catapulting 3DBioP capabilities and acceleration of application driven technologies.

Creating a Standardized Materials Library

Maintaining standardized 3DBioP materials library as off the shelf BioInks.

  • Understanding the additives and preservatives in BioInks and how they would affect the end product
  • How is the material and cell selection process carried out depending on the tissue, organ, scaffold, or implant that is to be printed.

Maintaining end-product quality control and quality assurance

  • engineering and control of the spatial distribution
  • printing quality of BioInk

Maintenance of printed materials in in-vitro

Understanding Needs during transition time post 3DBioP before tissue implantation.


Creating 3D models of endothelial organization for printing specifications.

Join The Conversation

>